Bard Meets With Security Analysts in New York.MURRAY HILL, N.J.--(BUSINESS WIRE)--Nov. 5, 1998--C. R. Bard, Inc. (NYSE NYSE See: New York Stock Exchange - BCR BCR B Cell Receptor BCR Business Communications Review (magazine) BCR Banca Comerciala Romana (Romanian bank) BCR Breakpoint Cluster Region BCR Benefit/Cost Ratio BCR Bay City Rollers ) senior executives Bill Longfield, chairman and chief executive officer; Tim Ring, John Weiland and Guy Jordan, group presidents; Jim Natale, president, Healthcare Services and Bill Bopp, executive vice president and chief financial officer, met with security analysts today to discuss Bard's accelerated growth profile following the divestiture of its coronary cath lab businesses (sold to AVE on October 1, 1998). These divestitures are part of Bard's strategic initiatives which also include a global reorganization around disease states with emphasis businesses in peripheral vascular, urological, oncological and surgical specialties. Bard has also restructured manufacturing and reduced selling, general and administrative costs administrative costs, n.pl the overhead expenses incurred in the operation of a dental benefits program, excluding costs of dental services provided. while increasing spending on research and development. These measures are designed to improve Bard's revenue and income growth rates Growth Rates The compounded annualized rate of growth of a company's revenues, earnings, dividends, or other figures. Notes: Remember, historically high growth rates don't always mean a high rate of growth looking into the future. for the next several years. In conjunction with its reorganization, Bard announced that it has offered an early retirement program to qualified employees at its New Jersey corporate headquarters. William C. Bopp, executive vice president and chief financial officer, announced his intention to retire at year-end 1998. C. R. Bard C. R. Bard, Inc. (NYSE: BCR) is one of the large S&P 500 companies of the United States, a surgical specialties and hospital medical device manufacturer in Murray Hill, New Jersey. It is named after its founder, who sold the company within only a few years of its founding. , Inc. headquartered in Murray Hill, New Jersey
This press release contains forward-looking statements, the accuracy of which is necessarily subject to risks and uncertainties. Management refers the reader to Bard's 1998 second quarter 10-Q for a detailed statement with regard to forward-looking statements. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion